化合物管理のヨーロッパ市場2020-2131

◆英語タイトル:EUROPE COMPOUND MANAGEMENT MARKET FORECAST 2020-2028
◆商品コード:INK20MY182
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年3月
◆ページ数:96
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:ヨーロッパ
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥131,250見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥157,500見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算¥210,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

KEY FINDINGSThe Europe compound management market is projected to record a CAGR of 13.85% during the forecast period. The presence of well-established and eminent manufacturing infrastructure facilities for drug development is one of the prominent drivers of market growth in the European region.

MARKET INSIGHTS
The analysis of the European compound management market growth includes the market assessment of countries like Poland, Belgium, Italy, France, Russia, the United Kingdom, Germany, and the Rest of Europe. In Germany, there is a growing demand for pharmaceuticals as a result of the rising geriatric population and prevailing chronic diseases, along with increasing demand for the production of new molecules for several therapeutics areas. The growth of the pharmaceutical market is supplemented by significant research advancements. The large presence of pharmaceutical companies, especially key domestic players, and their increasing focus on R&D activities with regard to drug development for therapeutic applications further proves beneficial for market growth in Germany.
While in countries like Italy, a large number of manufacturing units and investments have impacted the pharmaceutical production in a positive manner. The country is also set to become a prominent country in the clinical research domain. The advancing drug development and the growing pharma consumption are set to benefit the compound management market in Russia. The European region encompasses Belgium, who is a world leader in the pharmaceutical industry. The contribution of both the Belgian government and the pharmaceutical industry, in the form of investments, is further set to influence the overall market growth prospects of the compound management market during the forecast period.

COMPETITIVE INSIGHTS
Some of the eminent companies in the market are Axxam S.P.A., Beckman Coulter Inc, Evotec, Hamilton Company, Icagen Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. GROWTH IN R&D ACTIVITIES IN PHARMACEUTICAL AND BIOTECH SECTOR
3.2.2. GROWTH IN THE NUMBER OF CLINICAL TRIALS CONDUCTED
3.2.3. BIO BANKING SECTOR PUSHING FOR MARKET GROWTH
3.3. KEY RESTRAINTS
3.3.1. LACK OF SKILLED PROFESSIONALS
3.3.2. COMPOUND MANAGEMENT FACILITIES ARE CAPITAL INTENSIVE
4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER’S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
4.5. GROWTH STRATEGIES
4.5.1. ORGANIC GROWTH STRATEGIES
4.5.2. INORGANIC GROWTH STRATEGIES
5. MARKET BY PRODUCTS & SERVICES
5.1. PRODUCT
5.1.1. INSTRUMENTS
5.1.1.1. AUTOMATED COMPOUND/SAMPLE STORAGE SYSTEMS MARKET
5.1.1.2. MANUAL COMPOUND/SAMPLE STORAGE SYSTEMS MARKET
5.1.1.3. AUTOMATED LIQUID HANDLING SYSTEMS MARKET
5.1.2. SOFTWARE
5.2. SERVICES
6. MARKET BY SAMPLE TYPE
6.1. CHEMICAL COMPOUNDS
6.2. BIOSAMPLES
7. MARKET BY APPLICATION
7.1. DRUG DISCOVERY
7.2. GENE SYNTHESIS
7.3. BIOBANKING
8. MARKET BY END USER
8.1. PHARMACEUTICAL COMPANIES
8.2. BIOPHARMACEUTICAL COMPANIES
8.3. CONTRACT RESEARCH ORGANISATION
8.4. OTHERS
9. GEOGRAPHICAL ANALYSIS
9.1. EUROPE
9.1.1. UNITED KINGDOM
9.1.2. GERMANY
9.1.3. FRANCE
9.1.4. ITALY
9.1.5. RUSSIA
9.1.6. BELGIUM
9.1.7. POLAND
9.1.8. REST OF EUROPE
10. COMPANY PROFILES
10.1. AXXAM S.P.A.
10.2. BECKMAN COULTER INC
10.3. BIOASCENT
10.4. BIOSERO INC
10.5. BROOKS LIFE SCIENCES
10.6. EVOTEC
10.7. HAMILTON COMPANY
10.8. ICAGEN INC
10.9. LICONIC SYSTEMS
10.10. TCG LIFESCIENCES PVT LTD
10.11. TECAN TRADING AG
10.12. TITIAN SOFTWARE
10.13. SPT LABTECH (NAME CHANGED FROM TTP LABTECH)
10.14. WUXI APPTEC
10.15. HIGHRES BIOSOLUTIONS



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[化合物管理のヨーロッパ市場2020-2131]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆